Logo image of NOTE

FISCALNOTE HOLDINGS INC (NOTE) Stock Fundamental Analysis

NYSE:NOTE - New York Stock Exchange, Inc. - US3376551046 - Common Stock - Currency: USD

1.4  -0.1 (-6.67%)

After market: 1.36 -0.04 (-2.86%)

Fundamental Rating

1

Overall NOTE gets a fundamental rating of 1 out of 10. We evaluated NOTE against 82 industry peers in the Professional Services industry. Both the profitability and financial health of NOTE have multiple concerns. While showing a medium growth rate, NOTE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

NOTE had negative earnings in the past year.
NOTE had a negative operating cash flow in the past year.
NOTE Yearly Net Income VS EBIT VS OCF VS FCFNOTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -100M -200M -300M

1.2 Ratios

NOTE has a Return On Assets of -31.16%. This is amonst the worse of the industry: NOTE underperforms 91.14% of its industry peers.
NOTE has a worse Return On Equity (-265.67%) than 92.41% of its industry peers.
Industry RankSector Rank
ROA -31.16%
ROE -265.67%
ROIC N/A
ROA(3y)-56.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOTE Yearly ROA, ROE, ROICNOTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500 -1K

1.3 Margins

The Gross Margin of NOTE (81.61%) is better than 89.87% of its industry peers.
In the last couple of years the Gross Margin of NOTE has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for NOTE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5YN/A
NOTE Yearly Profit, Operating, Gross MarginsNOTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -100 -200 -300

0

2. Health

2.1 Basic Checks

NOTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NOTE has less shares outstanding
NOTE has a worse debt/assets ratio than last year.
NOTE Yearly Shares OutstandingNOTE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M 100M
NOTE Yearly Total Debt VS Total AssetsNOTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -3.00, we must say that NOTE is in the distress zone and has some risk of bankruptcy.
NOTE has a Altman-Z score of -3.00. This is amonst the worse of the industry: NOTE underperforms 92.41% of its industry peers.
NOTE has a Debt/Equity ratio of 5.12. This is a high value indicating a heavy dependency on external financing.
NOTE's Debt to Equity ratio of 5.12 is on the low side compared to the rest of the industry. NOTE is outperformed by 91.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.12
Debt/FCF N/A
Altman-Z -3
ROIC/WACCN/A
WACC10.57%
NOTE Yearly LT Debt VS Equity VS FCFNOTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.76 indicates that NOTE may have some problems paying its short term obligations.
The Current ratio of NOTE (0.76) is worse than 86.08% of its industry peers.
NOTE has a Quick Ratio of 0.76. This is a bad value and indicates that NOTE is not financially healthy enough and could expect problems in meeting its short term obligations.
NOTE has a Quick ratio of 0.76. This is amonst the worse of the industry: NOTE underperforms 84.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.76
NOTE Yearly Current Assets VS Current LiabilitesNOTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.00% over the past year.
Looking at the last year, NOTE shows a quite strong growth in Revenue. The Revenue has grown by 16.56% in the last year.
Measured over the past years, NOTE shows a very strong growth in Revenue. The Revenue has been growing by 26.71% on average per year.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)16.56%
Revenue growth 3Y26.71%
Revenue growth 5YN/A
Sales Q2Q%-13.44%

3.2 Future

The Earnings Per Share is expected to grow by 18.40% on average over the next years. This is quite good.
NOTE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.07% yearly.
EPS Next Y108.5%
EPS Next 2Y25.97%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue Next Year-9.88%
Revenue Next 2Y-3.18%
Revenue Next 3Y1.07%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NOTE Yearly Revenue VS EstimatesNOTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
NOTE Yearly EPS VS EstimatesNOTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3 -4

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOTE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOTE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NOTE Price Earnings VS Forward Price EarningsNOTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOTE Per share dataNOTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

NOTE's earnings are expected to grow with 18.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.97%
EPS Next 3Y18.4%

0

5. Dividend

5.1 Amount

NOTE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FISCALNOTE HOLDINGS INC

NYSE:NOTE (2/21/2025, 8:04:01 PM)

After market: 1.36 -0.04 (-2.86%)

1.4

-0.1 (-6.67%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)03-10 2025-03-10/amc
Inst Owners41.37%
Inst Owner Change-2.18%
Ins Owners12.7%
Ins Owner Change0.16%
Market Cap202.57M
Analysts82
Price Target3.38 (141.43%)
Short Float %7.66%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-57.84%
Min EPS beat(2)-148.28%
Max EPS beat(2)32.6%
EPS beat(4)2
Avg EPS beat(4)-46.3%
Min EPS beat(4)-148.28%
Max EPS beat(4)32.6%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.19%
Min Revenue beat(2)-3.67%
Max Revenue beat(2)-2.72%
Revenue beat(4)0
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-3.67%
Max Revenue beat(4)-2.5%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)3.57%
EPS NY rev (3m)-5.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.96%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.53
P/FCF N/A
P/OCF N/A
P/B 4.66
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0.92
BVpS0.3
TBVpS-1.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.16%
ROE -265.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.61%
FCFM N/A
ROA(3y)-56.25%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5YN/A
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 5.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.64%
Cap/Sales 5.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.76
Altman-Z -3
F-Score4
WACC10.57%
ROIC/WACCN/A
Cap/Depr(3y)38.78%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.56%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y108.5%
EPS Next 2Y25.97%
EPS Next 3Y18.4%
EPS Next 5YN/A
Revenue 1Y (TTM)16.56%
Revenue growth 3Y26.71%
Revenue growth 5YN/A
Sales Q2Q%-13.44%
Revenue Next Year-9.88%
Revenue Next 2Y-3.18%
Revenue Next 3Y1.07%
Revenue Next 5YN/A
EBIT growth 1Y22.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.19%
EBIT Next 3Y30.77%
EBIT Next 5YN/A
FCF growth 1Y48.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.13%
OCF growth 3YN/A
OCF growth 5YN/A